ciprofloxacin has been researched along with Infections, Serratia in 28 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Overall, moxifloxacin was the most effective of the four fluoroquinolones in reducing CFU/cornea in the rabbit model of gram-negative keratitis." | 3.72 | Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis. ( Caballero, AR; Dajcs, JJ; Girgis, DO; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA, 2004) |
| "Different complications were recorded: hydrocephalus and brain abscess in one case, respiratory and hemodynamic failure managed in the intensive care unit in the second, and brain hygroma in the third case." | 1.37 | [Iatrogenic meningitis after diagnosis lumbar puncture: 3 cases reports in the paediatric Children's Hospital of Tunis]. ( Barsaoui, S; Ben Jaballah, N; Bousnina, S; Bouziri, A; Hajji, N; Hariga, D; Kechrid, A; Sammoud, A; Smaoui, H, 2011) |
| "Nevertheless, Serratia infections are especially frequent in chronic granulomatous disease, which is a primary immunodeficiency that affects phagocytic cells of the innate immune system." | 1.35 | Acute dermal abscesses caused by Serratia marcescens. ( Bielsa, I; Carrascosa, JM; Domingo, H; Ferrándiz, C; Herrero, MJ; Ribera, M; Soria, X, 2008) |
| "The originality of our case is the recurrence of the disease on three occasions with the same bacterium isolated on each occasion, with disease remission after antibiotic therapy." | 1.31 | Neutrophilic eccrine hidradenitis secondary to infection with Serratia marcescens. ( Azoulay-Petit, C; Combemale, P; Dupin, M; Faisant, M; Kanitakis, J, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (17.86) | 18.2507 |
| 2000's | 10 (35.71) | 29.6817 |
| 2010's | 13 (46.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suh, B | 1 |
| Bae, IK | 1 |
| Kim, J | 1 |
| Jeong, SH | 1 |
| Yong, D | 1 |
| Lee, K | 1 |
| Hemarajata, P | 1 |
| Amick, T | 1 |
| Yang, S | 1 |
| Gregson, A | 1 |
| Holzmeyer, C | 1 |
| Bush, K | 1 |
| Humphries, RM | 1 |
| Sevencan, NO | 1 |
| Cakmakliogullari, EK | 1 |
| Ozkan, AE | 1 |
| Kayhan, B | 1 |
| Lau, JX | 1 |
| Li, JY | 1 |
| Yong, TY | 1 |
| Carlesimo, M | 1 |
| Pennica, A | 1 |
| Muscianese, M | 1 |
| Bottoni, U | 1 |
| Abruzzese, C | 1 |
| Giubettini, M | 1 |
| Pranteda, G | 2 |
| Cannon, TA | 1 |
| Partridge, DG | 1 |
| Boden, RA | 1 |
| Townsend, R | 1 |
| Stockley, I | 1 |
| Fournier, JB | 1 |
| Dabiri, G | 1 |
| Thomas, V | 1 |
| Skowron, G | 1 |
| Carson, P | 1 |
| Falanga, V | 1 |
| Gorret, J | 1 |
| Julie, G | 1 |
| Chevalier, J | 1 |
| Julie, C | 1 |
| Gaschet, A | 1 |
| Anne, G | 1 |
| Fraisse, B | 1 |
| Bernard, F | 1 |
| Violas, P | 1 |
| Philippe, V | 1 |
| Chapuis, M | 1 |
| Madeleine, C | 1 |
| Jolivet-Gougeon, A | 1 |
| Park, YJ | 1 |
| Kim, SY | 1 |
| Yu, JK | 1 |
| Kim, SI | 1 |
| Uh, Y | 1 |
| Hong, SG | 1 |
| Jongwook, L | 1 |
| Kwak, HS | 1 |
| Hornsey, M | 1 |
| Ellington, MJ | 1 |
| Doumith, M | 1 |
| Hudson, S | 1 |
| Livermore, DM | 1 |
| Woodford, N | 1 |
| Smaoui, H | 1 |
| Hariga, D | 1 |
| Hajji, N | 1 |
| Bouziri, A | 1 |
| Ben Jaballah, N | 1 |
| Barsaoui, S | 1 |
| Bousnina, S | 1 |
| Sammoud, A | 1 |
| Kechrid, A | 1 |
| Faro, J | 1 |
| Katz, A | 1 |
| Berens, P | 1 |
| Ross, PJ | 1 |
| Giráldez, P | 1 |
| Mayo, E | 1 |
| Pavón, P | 1 |
| Losada, A | 1 |
| Yang, HF | 1 |
| Cheng, J | 1 |
| Hu, LF | 1 |
| Ye, Y | 1 |
| Li, JB | 1 |
| Mahmoud, SS | 1 |
| Odak, S | 1 |
| Qazzafi, Z | 1 |
| McNicholas, MJ | 1 |
| Ma, J | 1 |
| Chan, JK | 1 |
| Thibodeaux, BA | 1 |
| Dajcs, JJ | 1 |
| Caballero, AR | 1 |
| Marquart, ME | 1 |
| Girgis, DO | 1 |
| O'Callaghan, RJ | 1 |
| García, FR | 1 |
| Paz, RC | 1 |
| González, RS | 1 |
| Ruiz, ES | 1 |
| Martín-Neda, FG | 1 |
| Rodríguez, MS | 1 |
| Martín, MR | 1 |
| Sarto, MS | 1 |
| Arguelles, HA | 1 |
| Bustínduy, MG | 1 |
| Cabrera, AN | 1 |
| Mah, FS | 1 |
| Romanowski, EG | 1 |
| Kowalski, RP | 1 |
| Yates, KA | 1 |
| Gordon, YJ | 1 |
| Soria, X | 1 |
| Bielsa, I | 1 |
| Ribera, M | 1 |
| Herrero, MJ | 1 |
| Domingo, H | 1 |
| Carrascosa, JM | 1 |
| Ferrándiz, C | 1 |
| Potel, G | 2 |
| Caillon, J | 2 |
| Xiong, YQ | 2 |
| Bugnon, D | 2 |
| Conte, PL | 1 |
| Drugeon, HB | 2 |
| Baron, D | 1 |
| Körner, RJ | 1 |
| Nicol, A | 1 |
| Reeves, DS | 1 |
| MacGowan, AP | 1 |
| Hows, J | 1 |
| Juvin, ME | 1 |
| Le Conte, P | 1 |
| Baron, DI | 1 |
| Leblanc, M | 1 |
| Ceccaldi, B | 1 |
| Cariou, B | 1 |
| Soullié, B | 1 |
| Le Berre, JP | 1 |
| Mayaudon, H | 1 |
| Dupuy, O | 1 |
| Bauduceau, B | 1 |
| Shields, JA | 1 |
| Shields, CL | 1 |
| Eagle, RC | 1 |
| Moster, M | 1 |
| Combemale, P | 1 |
| Faisant, M | 1 |
| Azoulay-Petit, C | 1 |
| Dupin, M | 1 |
| Kanitakis, J | 1 |
| Chen, KH | 1 |
| Kuang, TM | 1 |
| Hsu, WM | 1 |
1 review available for ciprofloxacin and Infections, Serratia
| Article | Year |
|---|---|
[Skin infection due to Serratia marcescens in an immunocompetent patient].
Topics: Abscess; Adult; Anti-Bacterial Agents; Cellulitis; Ciprofloxacin; Drug Therapy, Combination; Exudate | 2011 |
27 other studies available for ciprofloxacin and Infections, Serratia
| Article | Year |
|---|---|
Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Protein | 2010 |
Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cipr | 2018 |
An unusual location of squamous cell carcinoma and a rare cutaneous infection caused by serratia marcescens on the tumoral tissue: A case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Ciprofloxacin; Humans; Male; Sca | 2018 |
Non-contiguous multifocal vertebral osteomyelitis caused by Serratia marcescens.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Humans; Male; Meropenem; Middle Aged; Osteomyelitis; Serratia | 2015 |
Multiple skin ulcers due to Serratia marcescens in a immunocompetent patient.
Topics: Adolescent; Anti-Bacterial Agents; Ciprofloxacin; Diagnosis, Differential; Humans; Immunocompetence; | 2014 |
Case report of a successfully treated gentamicin and ciprofloxacin resistant Serratia marcescens prosthetic joint infection.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Ciprofloxacin; Gentamicins; Humans; Male; Mid | 2014 |
Serratia marcescens Bullous Cellulitis in a Splenectomized Patient: A Case Report and Review of the Literature.
Topics: Aged; Amputation, Surgical; Anti-Bacterial Agents; Biopsy; Cellulitis; Ciprofloxacin; Debridement; F | 2016 |
Childhood delayed septic arthritis of the knee caused by Serratia fonticola.
Topics: Adult; Anti-Bacterial Agents; Arthritis, Infectious; Ceftriaxone; Ciprofloxacin; Crataegus; Drainage | 2009 |
Spread of Serratia marcescens coharboring aac(6')-Ib-cr, bla CTX-M, armA, and bla OXA-1 carried by conjugative IncL/M type plasmid in Korean hospitals.
Topics: Anti-Infective Agents; Ciprofloxacin; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Multipl | 2009 |
Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY-HasF efflux system also active against ciprofloxacin and cefpirome.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biological Transport, Active; Cefpirome; Cephalosporins; | 2010 |
[Iatrogenic meningitis after diagnosis lumbar puncture: 3 cases reports in the paediatric Children's Hospital of Tunis].
Topics: beta-Lactam Resistance; Brain Abscess; Brain Damage, Chronic; Ciprofloxacin; Drug Therapy, Combinati | 2011 |
Premature termination of nursing secondary to Serratia marcescens breast pump contamination.
Topics: Adult; Anti-Bacterial Agents; Breast Feeding; Ciprofloxacin; Equipment Contamination; Female; Humans | 2011 |
Plasmid-mediated quinolone resistance in extended-spectrum-β-lactamase- and AmpC β-lactamase-producing Serratia marcescens in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; China; Ciproflox | 2012 |
Primary total knee arthroplasty infected with Serratia marcescens.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Ciprofloxacin; Drug Thera | 2012 |
Granulomatous osteomyelitis caused by bacteria other than mycobacteria: a report of two cases.
Topics: Adult; Ampicillin; Anti-Infective Agents; Ciprofloxacin; Female; Granuloma; Humans; Male; Middle Age | 2002 |
Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Cornea; Eye I | 2004 |
Cutaneous infection caused by Serratia marcescens in a child.
Topics: Anti-Infective Agents; Biopsy; Child; Ciprofloxacin; Granuloma; Humans; Serratia Infections; Serrati | 2006 |
Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Corneal Ulcer; Disease Model | 2007 |
Acute dermal abscesses caused by Serratia marcescens.
Topics: Abscess; Acute Disease; Adult; Ciprofloxacin; Humans; Male; Neutrophils; Serratia Infections; Serrat | 2008 |
[Critical serum concentration of antibiotics. A therapeutic tool and means of comparative evaluation].
Topics: Animals; Ceftazidime; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Evaluation; Endocarditis | 1995 |
Ciprofloxacin resistant Serratia marcescens endocarditis as a complication of non-Hodgkin's lymphoma.
Topics: Azlocillin; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Gentamicins; | 1994 |
In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis.
Topics: Animals; Ciprofloxacin; Colony Count, Microbial; Endocarditis, Bacterial; Female; Humans; Infusions, | 1994 |
Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Escherichia coli; Escherichia coli | 1997 |
[Serratia odorifera biovar 1 bronchial infection].
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bronchial Diseases; Bronchoalveolar Lavage Fluid; Ci | 1999 |
Localized infection by Serratia marcescens simulating a conjunctival neoplasm.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Conjunctival Diseases; Conjunctival N | 2000 |
Neutrophilic eccrine hidradenitis secondary to infection with Serratia marcescens.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Ependymoma; Hidradenitis; Humans; Male; Postoperative C | 2000 |
Serratia Marcescens corneal ulcer as a complication of orthokeratology.
Topics: Anti-Infective Agents; Astigmatism; Child; Ciprofloxacin; Contact Lenses; Cornea; Corneal Ulcer; Eye | 2001 |